Inventor · disambiguated record
Yihong Li
Also filed as: LI YIHONG
17 granted patents·13 pending applications·266 citations·filing 1996–2023
93Inventor score
Top patents by PatentIndex Score
30 records- 0192US6437138B13-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 2000·Granted Aug 20, 2002·54 cites·2 claims
- 0292US5629325A3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 1996·Granted May 13, 1997·106 cites·9 claims
- 0388US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0488US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 0587US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 0686US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 0785US11634396B2Opioid receptor modulatorsEPIODYNE INC·Filed 2022·Granted Apr 25, 2023·1 cites·16 claims
- 0883US6627767B2Amino(oxo) acetic acid protein tyrosine phosphatase inhibitorsABBOTT LAB·Filed 2001·Granted Sep 30, 2003·15 cites·24 claims
- 0982US11352316B2Opioid receptor modulators and products and methods related theretoEPIODYNE INC·Filed 2020·Granted Jun 7, 2022·1 cites·20 claims
- 1080US6127386A3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 1997·Granted Oct 3, 2000·47 cites·13 claims
- 1180US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 1279US12312345B2Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2023·Granted May 27, 2025·0 cites·32 claims
- 1375US8058425B2Purine derivatives as kinase inhibitorsENGLER THOMAS ALBERT·Filed 2011·Granted Nov 15, 2011·5 cites·8 claims
- 1474US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 1569US7405305B2Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitorsLILLY CO ELI·Filed 2003·Granted Jul 29, 2008·6 cites·9 claims
- 1668US12168648B2Opioid receptor modulatorsEPIODYNE INC·Filed 2023·Granted Dec 17, 2024·0 cites·20 claims
- 1768US9758495B2Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Sep 12, 2017·1 cites·37 claims
- 1867US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 1965US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 2064US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 2156US2023086732A1Photoactive fluorescent compounds and use thereof for labeling of proteinsEIKON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2256US2023123856A15-fluoronicotinamide derivatives and uses thereofTENAYA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2355US2009305252A1Methods and species-specific primers for detection and quantification of Streptococcus mutans and Streptococcus sanguinis in mixed bacterial samplesLI YIHONG·Filed 2008·Application pending·0 cites
- 2454US2021147343A1Opioid receptor modulators and products and methods related theretoEPIODYNE INC·Filed 2019·Application pending·0 cites
- 2548US2008207685A1Heterocyclic Compounds As Modulators Of Peroxisome Proliferator Activated Receptors, Useful For The Treatment And/Or Prevention Of Disorders Modulated By A PparLILLY CO ELI·Filed 2004·Application pending·0 cites
- 2647US2011294792A1Purine derivatives as kinase inhibitorsENGLER THOMAS ALBERT·Filed 2011·Application pending·0 cites
- 2744US11274105B2Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonistsAMGEN INC·Filed 2019·Granted Mar 15, 2022·0 cites·15 claims
- 2844US6001849AFuropyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 1997·Granted Dec 14, 1999·6 cites·14 claims
- 2939US6984661B2Urea linker derivatives for use as PPAR modulatorsLILLY CO ELI·Filed 2003·Granted Jan 10, 2006·0 cites·16 claims
- 3037US2002151712A13-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmissionFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yihong Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →